35 results on '"Freiberg, Josefine"'
Search Results
2. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells
3. Artificial Tears, Preservatives and so what?
4. Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive Reliability (FOREVER)—A cohort study in a Danish high street optician setting:Design and methodology
5. Longitudinal associations of retinal vessel morphology with intraocular pressure and blood pressure at follow‐up visit—Findings from a Danish eye and vision cohort, Project FOREVER.
6. Artificial tears, preservatives, so what?
7. Comparing the effect of benzalkonium chloride‐preserved, polyquad‐preserved, and preservative‐free prostaglandin analogue eye drops on cultured human conjunctival goblet cells
8. Central contrast sensitivity as an outcome measure in randomized controlled trials in glaucoma ‐ a systematic review
9. Association between self‐reported eye health and self‐reported general health. Results from the FOREVER questionnaire
10. Automated analysis of vessel morphometry in retinal images from a Danish high street optician setting
11. Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive Reliability (FOREVER)—A cohort study in a Danish high street optician setting: Design and methodology.
12. Automated analysis of vessel morphometry in retinal images from a Danish high street optician setting.
13. rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension ‐ a Cochrane systematic review
14. Glaucoma and cardioprotective medication
15. Central Contrast sensitivity as an outcome measure in randomised controlled trials in glaucoma – a systematic review
16. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
17. An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival
18. Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop
19. An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival
20. Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop:Effect on cultured human conjunctival goblet cells and their physicochemical properties
21. The physicochemical properties of preserved and preservative-free latanoprost eye drops and their impact on human conjunctival goblet cells
22. Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension:a systematic review
23. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
24. Glaucoma clinical research: Trends in treatment strategies and drug discovery
25. The physicochemical properties of preserved and preservative‐free latanoprost eye drops and their impact on human conjunctival goblet cells
26. Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops
27. Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development
28. Comparative efficacy and safety of preserved versus preservative‐free beta‐blockers in patients with glaucoma or ocular hypertension: a systematic review
29. Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops
30. Glaucoma Clinical Research:Trends in Treatment Strategies and Drug Development
31. Clement Freiberg, Josefine
32. An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w / v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival.
33. Comparative efficacy and safety of preserved versus preservative‐free beta‐blockers in patients with glaucoma or ocular hypertension: a systematic review.
34. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
35. The Multifaceted Non-Genetic Risk Factors for Primary Open-Angle Glaucoma - An Overview of Systematic Reviews.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.